The global demand for Gene Panel Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Gene panel is a diagnostic test used to narrow down a diagnosis when the patient shows symptoms that can be caused by a variety of conditions or when variants in multiple genes can cause the suspected condition. Gene panel tests can examine large numbers of genes which helps provide cancer information and provides a secure diagnosis to prevent cancer spread. Gene panel are used in diagnostics and treatments such as cancer risk assessment, syndrome-specific diagnostics, disease penetration, and many other applications.
The significant factor attributing to the market's growth is the rising incidence and prevalence of chronic diseases. Moreover, increasing technological advancement in diagnostics services and modernization in healthcare techniques are driving the market's growth. Also, the growing ongoing research and development drive the gene panel market. Furthermore, the increasing number of cancer cases in males and females and the benefits of the gene panel market to fight cancer drive market growth. However, high prices and serious doubts among individuals about the authenticity of genetic reports are the major restraints of the gene panel market growth. In addition, growing awareness about the potential benefits of genetic testing, increasing demand for advanced medical testing, and rising demand for targeted approaches and personalized medicine are the primary drivers of the growth of the global gene panel market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene panel. The growth and trends of gene panel industry provide a holistic approach to this study.
This section of the gene panel market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
- Test Kits
- Testing Services
- Amplicon-Based Approach
- Hybridization-Based Approach
- Predesigned Gene Panel
- Customized Gene Panel
By End User
- Cancer Risk Assessment (Syndrome-Specific, High-Penetrance, High And Moderate-Penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases)
- Other Applications
- Research And Academic Institutes
- Hospital And Diagnostic Laboratories
- Pharmaceutical And Biotechnology Companies
This section covers the regional outlook, which accentuates current and future demand for the Gene Panel market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Gene Panel Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene panel market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.